EUVIMEDEUVIMED entdecken
Crossref

PD-1 blockade unleashes local hepatitis B virus-related B cell response inhibiting hepatocellular carcinoma

Shuling Chen, Yuanqi Wang, Jingying Chen, Wenxuan Xie, Jianyu Chen, Guanrui Liao, Xiaoxue Ren, Kai Lei, Yuting Zhang, Shu Wang, Ye Yang, Youmei Kang und 9 weitere

Cancer Cell · 2026-08 · 44 (8) · 1549-1567.e12

DOI: 10.1016/j.ccell.2026.06.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2026-08. Verfasst von Shuling Chen und 20 weiteren Autor:innen. Beteiligte Einrichtung: Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China; Institute of…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Hepatitis B virus, B-Lymphocytes. Die Arbeit nennt 101 Literaturangaben. Gefördert von: Guangdong Provincial Pearl River Talents Program, National Natural Science Foundation of China, Guangdong Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevailing notion is that effector T cell activation mediates anti-PD-1 efficacy in cancer. Here, we conducted a mechanistic study parallel to our phase 2 trial of perioperative anti-PD-1 therapy in patients with resectable recurrent hepatocellular carcinoma (HCC) (NCT04615143) to study its mechanism of action. Late-recurrence patients present two distinct subtypes characterized by T cell or B cell dominant responses in the tumor microenvironment by dynamic single-cell multi-omics analysis. Clonal antibody repertoire analysis and spatially paired scRNA-seq/BCR-seq reveal somatic hypermutation promoting antibody binding against hepatitis B virus core antigen (HBcAg) within tumor tertiary lymphoid structures (TLSs) in these type B-late recurrence patients. Mechanistically, HBcAg is exported into the extracellular space, triggering local B cell and antibody responses and complement activation. In mice, these high-affinity HBcAg-reactive antibodies lead to complement-mediated antitumor activity with enhanced anti-PD-1 efficacy. Thus, we uncover enhanced anti-virus B cell immunity within the TLS as a mechanism to anti-PD-1 in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHepatitis B virusB-LymphocytesProgrammed Cell Death 1 ReceptorImmune Checkpoint InhibitorsHumansAnimalsMiceTumor MicroenvironmentHepatitis B Core AntigensFemaleNeoplasm Recurrence, Local

Stichwörter der Autor:innen

B-cell responseanti-PD-1antibody affinityhepatitis B virushepatocellular carcinomaimmune checkpoint blockadetertiary lymphoid structures

Substanzen

Programmed Cell Death 1 ReceptorImmune Checkpoint InhibitorsPDCD1 protein, humanHepatitis B Core Antigens

Autor:innen und Institutionen

  • Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China; Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospit…
  • Center of Hepato-Pancreato-Biliary Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China.
  • Department of Oncology, Cancer Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China; Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong 510080, China.
  • Department of Oncology, Cancer Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China.
  • Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China.
  • Institute of Precision Medicine, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China.

Förderung

  • Guangdong Provincial Pearl River Talents Program
  • National Natural Science Foundation of China
  • Guangdong Provincial Natural Science Foundation
  • Special Project for Research and Development in Key Areas of Guangdong Province
  • National Science Fund for Distinguished Young Scholars

Zitieren

APA

Chen, S., Wang, Y., Chen, J., Xie, W., Chen, J., Liao, G., Ren, X., Lei, K., Zhang, Y., Wang, S., Yang, Y., Kang, Y., Chen, Q., Wen, Y., Lai, J., Yang, P., Shen, S., Li, S., Yiu-Nam Lau, J., …, & Kuang, M. (2026). PD-1 blockade unleashes local hepatitis B virus-related B cell response inhibiting hepatocellular carcinoma. Cancer Cell, 44(8), 1549-1567.e12. https://doi.org/10.1016/j.ccell.2026.06.010

Vancouver

Chen S, Wang Y, Chen J, Xie W, Chen J, Liao G, et al. PD-1 blockade unleashes local hepatitis B virus-related B cell response inhibiting hepatocellular carcinoma. Cancer Cell. 2026;44(8):1549-1567.e12. doi:10.1016/j.ccell.2026.06.010

BibTeX
@article{Chen2026,
  author = {Chen, Shuling and Wang, Yuanqi and Chen, Jingying and Xie, Wenxuan and Chen, Jianyu and Liao, Guanrui and Ren, Xiaoxue and Lei, Kai and Zhang, Yuting and Wang, Shu and Yang, Ye and Kang, Youmei and Chen, Qiaoyi and Wen, Yixi and Lai, Jiaming and Yang, Pengyuan and Shen, Shunli and Li, Shaoqiang and Yiu-Nam Lau, Johnson and Yin, Changjun and Kuang, Ming},
  title = {PD-1 blockade unleashes local hepatitis B virus-related B cell response inhibiting hepatocellular carcinoma},
  journal = {Cancer Cell},
  year = {2026},
  volume = {44},
  number = {8},
  pages = {1549--1567.e12},
  doi = {10.1016/j.ccell.2026.06.010}
}
Kostenlos starten →